Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q3 EPS of ($0.37), $0.03 worse than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.